Paper36280752
Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation.
Wolf G and 7 others. Mol Psychiatry, 2023. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation. Papers, record 36280752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36280752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hallucinogens | Major topic |
| Schizophrenia | Major topic |
| Psychotic Disorders | Major topic |
| Antipsychotic Agents | Major topic |
| Animals | |
| Humans |
Source PubMed
References212
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31664453 | Schizophrenia-An Overview. | JAMA Psychiatry | 2020 | https://conductscience.org/library/papers/31664453 | PubMed |
| 2 | 30262987 | Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics. | J Exp Neurosci | 2018 | https://conductscience.org/library/papers/30262987 | PubMed |
| 3 | 23609382 | Memantine add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized, double-blind, placebo-controlled study. | J Clin Psychopharmacol | 2013 | https://conductscience.org/library/papers/23609382 | PubMed |
| 4 | 29898390 | Psychedelics Promote Structural and Functional Neural Plasticity. | Cell Rep | 2018 | https://conductscience.org/library/papers/29898390 | PubMed |
| 5 | 8251869 | Adverse consequences of lysergic acid diethylamide. | Addiction | 1993 | https://conductscience.org/library/papers/8251869 | PubMed |
| 6 | 16269092 | Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. | J Cogn Neurosci | 2005 | https://conductscience.org/library/papers/16269092 | PubMed |
| 7 | 22561603 | Ketamine-enhanced immobility in forced swim test: a possible animal model for the negative symptoms of schizophrenia. | Prog Neuropsychopharmacol Biol Psychiatry | 2012 | https://conductscience.org/library/papers/22561603 | PubMed |
| 8 | 16172203 | Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. | N Engl J Med | 2005 | https://conductscience.org/library/papers/16172203 | PubMed |
| 9 | 17015232 | Neurobiology of schizophrenia. | Neuron | 2006 | https://conductscience.org/library/papers/17015232 | PubMed |
| 10 | 32110026 | Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment. | Neuropsychiatr Dis Treat | 2020 | https://conductscience.org/library/papers/32110026 | PubMed |
| 11 | 31065731 | MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials. | Psychopharmacology (Berl) | 2019 | https://conductscience.org/library/papers/31065731 | PubMed |
| 12 | 32042038 | Emotions and brain function are altered up to one month after a single high dose of psilocybin. | Sci Rep | 2020 | https://conductscience.org/library/papers/32042038 | PubMed |
| 13 | 20618446 | Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. | Genes Brain Behav | 2010 | https://conductscience.org/library/papers/20618446 | PubMed |
| 14 | 25392249 | Clinical characteristics of individuals with schizophrenia and hallucinogen persisting perception disorder: a preliminary investigation. | J Dual Diagn | 2014 | https://conductscience.org/library/papers/25392249 | PubMed |
| 15 | 17349858 | Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. | Int Rev Neurobiol | 2007 | https://conductscience.org/library/papers/17349858 | PubMed |
| 16 | 33328244 | Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. | Pharmacol Rev | 2021 | https://conductscience.org/library/papers/33328244 | PubMed |
| 17 | 31568558 | Acute effects of lysergic acid diethylamide (LSD) on resting brain function. | Swiss Med Wkly | 2019 | https://conductscience.org/library/papers/31568558 | PubMed |
| 18 | 25744618 | Psychedelics not linked to mental health problems or suicidal behavior: a population study. | J Psychopharmacol | 2015 | https://conductscience.org/library/papers/25744618 | PubMed |
| 19 | 33252694 | Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants. | Int J Neuropsychopharmacol | 2021 | https://conductscience.org/library/papers/33252694 | PubMed |
| 20 | 1149803 | Behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rats and mice. | Eur J Pharmacol | 1975 | https://conductscience.org/library/papers/1149803 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42471435 | Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophrenia. | Neuropsychopharmacology | 2026 | https://conductscience.org/library/papers/42471435 | PubMed |
| 42345450 | The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential. | J Psychopharmacol | 2026 | https://conductscience.org/library/papers/42345450 | PubMed |
| 42154264 | Efficacy and safety of Nrf2 activators for schizophrenia: a systematic review and meta-analysis. | Eur Arch Psychiatry Clin Neurosci | 2026 | https://conductscience.org/library/papers/42154264 | PubMed |
| 41446307 | How do psychedelics impact people with a history of non-affective psychosis? A qualitative study. | Front Psychiatry | 2025 | https://conductscience.org/library/papers/41446307 | PubMed |
| 40530408 | Naturalistic Psychedelic Use and Psychotic Symptoms: A Cross-Sectional Study of Individuals with a Personal or Family History of Psychotic or Bipolar Disorders. | Psychedelic Med (New Rochelle) | 2025 | https://conductscience.org/library/papers/40530408 | PubMed |
| 40514369 | Synergistic behavioral and neuroplastic effects of psilocybin-NMDAR modulator administration. | Transl Psychiatry | 2025 | https://conductscience.org/library/papers/40514369 | PubMed |
| 40162511 | Longitudinal associations of naturalistic psychedelic use with psychotic and manic symptoms. | Psychol Med | 2025 | https://conductscience.org/library/papers/40162511 | PubMed |
| 39592825 | Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies. | Mol Psychiatry | 2025 | https://conductscience.org/library/papers/39592825 | PubMed |
| 39446321 | Theta Burst Stimulation Protocols for Schizophrenia: A Systematic Review and Network Meta-Analysis. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/39446321 | PubMed |
| 39260466 | A Computational Account of the Development and Evolution of Psychotic Symptoms. | Biol Psychiatry | 2025 | https://conductscience.org/library/papers/39260466 | PubMed |
| 38923845 | Psychotomimetic compensation versus sensitization. | Pharmacol Res Perspect | 2024 | https://conductscience.org/library/papers/38923845 | PubMed |
| 38919636 | Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder. | Front Psychiatry | 2024 | https://conductscience.org/library/papers/38919636 | PubMed |
| 38491857 | Psychiatric risks for worsened mental health after psychedelic use. | J Psychopharmacol | 2024 | https://conductscience.org/library/papers/38491857 | PubMed |
| 38280572 | Longitudinal associations between psychedelic use and psychotic symptoms in the United States and the United Kingdom. | J Affect Disord | 2024 | https://conductscience.org/library/papers/38280572 | PubMed |
| 37945694 | Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders. | Mol Psychiatry | 2024 | https://conductscience.org/library/papers/37945694 | PubMed |
| 37935376 | Ligand recognition and G-protein coupling of trace amine receptor TAAR1. | Nature | 2023 | https://conductscience.org/library/papers/37935376 | PubMed |
| 37899392 | Psychedelics action and schizophrenia. | Pharmacol Rep | 2023 | https://conductscience.org/library/papers/37899392 | PubMed |
| 37759040 | Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics. | Mol Psychiatry | 2023 | https://conductscience.org/library/papers/37759040 | PubMed |
| 37358825 | Social Psychopharmacology: Novel Approaches to Treat Deficits in Social Motivation in Schizophrenia. | Schizophr Bull | 2023 | https://conductscience.org/library/papers/37358825 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HTR2A | 3356 | PubTator's text mining | https://conductscience.org/library/genes/3356 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36280752
GET https://conductscience.org/api/papers/v1/36280752/references?page=2